Growth Metrics

Pacira BioSciences (PCRX) Short-Term Debt repayments (2025 - 2026)

Pacira BioSciences has reported Short-Term Debt repayments over the past 2 years, most recently at $5.0 million for Q1 2026.

  • For Q1 2026, Short-Term Debt repayments changed N/A year-over-year to $5.0 million; the TTM value through Mar 2026 reached $10.0 million, changed N/A, while the annual FY2025 figure was $10.0 million, N/A changed from the prior year.
  • Short-Term Debt repayments for Q1 2026 was $5.0 million at Pacira BioSciences, roughly flat from $5.0 million in the prior quarter.
  • Over five years, Short-Term Debt repayments peaked at $5.0 million in Q4 2025 and troughed at $5.0 million in Q4 2025.